H.C. Wainwright Reiterates Buy Rating on Crinetics (CRNX)

September 26, 2025 6:47 AM EDT Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $81.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented: "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login